European shares propelled to 8-month highs by renewed vaccine hopes


BENGALURU (Reuters) - European shares jumped to an eight month high on Monday after drugmakers Pfizer and BioNTech flagged strong progress in their COVID-19 vaccine, while Joe Biden's presidential victory raised hopes of a more stable US trade policy.

Pfizer Inc and BioNTech SE said the experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

STOXX 600 , FTSE 100 , Pfizer , Biontech , vaccine , Covid-19 , shares

   

Next In Business News

Nintendo expects to sell 13.5 mln Switch units this year
M&A Securities and Newparadigm back Siab’s acquisition of Taghill with rights issue
Saudi Aramco maintains dividend despite lower net income in Q1
Pekat unit in negotiations over purchase of stake in electrical power solutions firm
Asia shares rise on rate cut bets; Aussie slips on RBA
UBS reports first profit since taking over Credit Suisse
Amazon to spend nearly US$9bil to expand cloud infra in Singapore
FBM KLCI pushes past 1,600
Ringgit opens higher against US$, other major currencies
KLK's recruitment issues to be short-lived, say analysts

Others Also Read